IPCA Labs Q3 Results: Shares rise 6% as net profit jumps 38%; margin expands from last year

The pharma company’s revenue rose 9% on-year to ₹2,245.4 crore during the quarter. Indian formulations income surged 13% to ₹877 crore.

Leave a Reply

Your email address will not be published. Required fields are marked *